New Products and Industry News

Once-a-day moisturizer combats xerosis effects

   Coloplast Corp. (Atlanta, Ga.) has introduced Sween 24, a routine, long-lasting, once-a-day moisturizer for dry, flaky skin associated with xerosis. The non-greasy formulation spreads easily, absorbs quickly, and is clinically proven to moisturize the skin for 24-hours.

   Because the product requires only one application per day to continuously moisturize patients" skin, nursing time is minimized while protocol compliance is maximized. Non-irritating and non-sensitizing, the product is formulated with no lanolin, no alcohol, and no fragrances, making it a good choice for the most sensitive patients.

   For more information call (800) 533-0464.

Absorptive foam dressing stays in place with fewer changes

   DermaRite Industries (Paterson, NJ) has introduced Derma Levin, a sterile, waterproof foam dressing. The dressing maintains a moist wound environment and absorbs four times more excess exudates than hydrocolloids. Its nonadherent wound contact layer and a semipermeable polyurethane film top layer conform well in awkward-to-dress areas that stays in place with fewer changes. The dressing also helps prevent bacterial contamination during the healing process and is effective in managing chronic and acute wounds, low- to moderately exuding, partial- and full-thickness wounds, Stages II, III, and IV ulcers, pressure ulcers, leg ulcers, and donor sites.

   For a free sample, please call (973) 569-9000 and refer to order #280HMP. 

Soothing cream has many uses

   Apollo Corporation’s (Denver, Colo.) A. Sween’s Apollo Cream helps promote healing with natural vitamins A and D and natural lanolin oil. This vanishing cream easily penetrates the skin and contains beeswax to form a protective layer shielding the skin from irritants. The cream can be used for incontinent care, urine scald, diarrheal skin breakdown, diaper rash, scrapes, burns, psoriasis, eczema, ostomy care, around decubitus sites, and similar instances of compromised skin.

   For information, please call (800) 247-5490.

Bedside care foam products added to company line

   Coloplast Corp. (Atlanta, Ga.) introduced Bedside Care Foam and Bedside Care Unscented Foam for no-rinse, full body shampoo and perineal cleansing. These alcohol and aerosol-free bedside bathing products have been designed to help meet the challenges of time-constrained nursing professionals.

   Both products have been formulated with ingredients that clean, moisturize, and condition the skin, perineum, hair, and scalp. They may be used for routine tub and shower bathing or for no-rinse bathing and shampooing. The unscented version is the only fragrance-, dye- and alcohol-free, non-aerosol foam cleanser on the market.

   For more information, please call (800) 533-0464.

New manufacturer/distributor named for foot ulcer products

   DM Systems, Inc.( Evanston, Ill.), manufacturer of the Heelift® Suspension Boot and other wound care, rehab, and orthopedic products, announced that Darco (Europe) GmbH will be a licensed manufacturer and distributor of Heelift® Original and Heelift® Smooth Suspension Boots and Elbowlift® Suspension Pad for the European market. Heelift products treat and prevent heel pressure ulcers by lifting the heel with an elevation pad and suspending the heel in protective space, transferring pressure from the heel to the lower leg. The elbow pad cushions and elevates the elbow to minimize surface contact, protecting the olecranon and olecranon bursa from friction burns and contusions.

   For information, visit www.dmsystems.com or call (800) 254-5438.

Diabetic neuropathy study demonstrates reversal of symptoms

   Anodyne® Therapy (Tampa, Fla.) published results of its second peer-reviewed clinical study to demonstrate restoration of sensation in the feet of diabetic patients with peripheral neuropathy. The study, conducted at the Joslin Diabetes Center at Morton Plant Hospital in Clearwater, Fla., showed that after 12 45-minute treatments, a 46% improvement in sensation was noted and pain decreased by 45%. Additionally, 70% of patients reported an improvement in balance and less fear of falling.

   Neuropathy related to conditions such as diabetes is usually considered to be progressive and irreversible and is a major contributing factor to chronic foot wounds, causing falls and more than 60,000 amputations per year. The cost of diabetic neuropathy alone to the US healthcare system has been reported to exceed $37 billion per year.

   The treatments are currently available at outpatient facilities, hospitals, nursing homes, physician offices, and home health agencies nationwide. Products are also available for convenient home use.

   For more information, visit www.anodynetherapy.com.

Company sells advanced wound business product

   HydroCision Inc. (Andover, Mass. and London, UK) announced that its VersaJet surgical debridement product has been acquired by the Advanced Wound management business of Smith + Nephew to add to Smith + Nephew"s growing range of advanced wound bed preparation products.

   The product is a specialized fluid jet instrument that enables surgeons to easily remove damaged tissue and contaminants from surgical, traumatic, and chronic wounds in a precise and safe manner. Approved for use in the US, Canada, and the European Union, it was launched in January 2003.

   For more information, visit www.hydrocision.com.